With many thanks to collaborators @meganodris.bsky.social @gabribdsantos.bsky.social @wmdesouza.bsky.social @mugkraemer.bsky.social @hsalje.bsky.social @pducambridge.bsky.social and others!

🎯 Finally, age-dependent risks in morbidity and mortality mean that targeting broad age groups in federative units with high CHIKV burden would maximize efficiency as immunization begins

On average, 4 in 100,000 infections were fatal. This number rises to 40 deaths per 100,000 infections in individuals aged 70+.

🔎Approximately 1% of infections were laboratory confirmed, but female infections were 1.8 times more likely to be detected.

We found that 18.3% of the population was infected between 2014 and 2024 (equivalent to 40M infections), with substantial spatiotemporal heterogeneities in attack rates.

📈 Pooling information from serology, case, and mortality data, we reconstructed the epidemiology of CHIKV in Brazil and projected the potential impact of recently licensed vaccines. Some key results:

Apologies for the website glitch - it's www.pdu.gen.cam.ac.uk

Thanks both! Excited to be part of this list! @meganodris.bsky.social @zulmacucunuba.bsky.social

Could I be added to the contributor list please?